Related Experiment Video
Updated: Dec 25, 2025
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Huntingtin Lowering Strategies.
Franz Marxreiter1,2, Judith Stemick1, Zacharias Kohl3
1Huntington's Disease Outpatient Clinic, Department of Molecular Neurology, University Hospital Erlangen, Schwabachanlage 6, 91054 Erlangen, Germany.
Antisense oligonucleotide technology is being investigated to lower Huntingtin levels in Huntington's disease (HD). This approach, targeting the Huntingtin gene (HTT), shows promise for future HD patient treatments.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Huntington's disease (HD) is an autosomal dominantly inherited neurodegenerative disorder caused by a CAG-repeat expansion in the Huntingtin gene (HTT).
- Recent advancements in genetic engineering and understanding of HD pathophysiology have paved the way for novel therapeutic strategies.
Purpose of the Study:
- To provide an overview of current and upcoming huntingtin-lowering strategies for Huntington's disease.
- To discuss the implications of these strategies for the future treatment of HD patients.
Main Methods:
- Review of ongoing clinical trials utilizing antisense oligonucleotide technology and RNA interference.
- Examination of therapeutic strategies targeting genome editing, RNA interference, and protein degradation.
Main Results:
- Huntingtin-lowering approaches, particularly RNA interference, are entering the clinical trial phase.
- These strategies aim to reduce Huntingtin levels by targeting its gene (HTT) or RNA.
Conclusions:
- Huntingtin-lowering therapies, especially those using RNA interference, represent a promising avenue for treating Huntington's disease.
- Further research and clinical trials are crucial to determine the efficacy and implications of these innovative treatments for HD patients.
More Related Videos
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
11:22Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Published on: June 27, 2018
